ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag culture funding clinical trials neuroscience

Pelizaeus-Merzbacher disease neural stem cell transplantation
Neural Stem Cell Transplantation Crawls Toward the Clinic
Ashley P. Taylor | Oct 29, 2019 | 9 min read
Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
illustration of a brain divided into 4 puzzle pieces
Why Autism Therapies Have an Evidence Problem
Rachel Zamzow | Apr 14, 2022 | 7 min read
Some experts argue that better trials are needed before putting interventions into practice.
An illustration of flowers in the shape of the female reproductive tract
Uterus Transplants Hit the Clinic
Jef Akst | Aug 1, 2021 | 10+ min read
With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019 | 10+ min read
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Companies Halt First Alzheimer Vaccine Trial
Douglas Steinberg | Apr 1, 2002 | 6 min read
One cutting-edge neuroscience issue is whether a vaccine can cure Alzheimer disease (AD). A much-ballyhooed clinical trial recently sought an answer. But a mistrial was soon declared, and scientific sleuths now face a fresh mystery: Why did 15 trial subjects get sick? The vaccine, developed by Elan Corp., contained Ab, the peptide widely believed to trigger AD by forming brain-clogging amyloid plaques. When Elan researchers vaccinated transgenic mice that had developed AD-like pathology, plaque
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
2011 World Science Festival: A look back
The Scientist | Jun 10, 2011 | 5 min read
The Scientist covered some of the events that made this year's festival memorable.
Marijuana Ruling Exempts Federally Funded Research
A. J. S. Rayl | Jun 24, 2001 | 10+ min read
"In the case of the Controlled Substances Act, the statute reflects a determination that marijuana has no medical benefits worthy of an exception (outside the confines of a government-approved research project)." -Justice Clarence Thomas1 The Supreme Court's recent ruling against manufacturing and distributing medicinal cannabis does not appear to have had any immediate impact on either basic or clinical research studies under way. Some investigators, however, remain leery about the potential f
The Promise of Scientific Partnerships with People on the Spectrum
Laura Dattaro, Spectrum | Jan 18, 2021 | 10+ min read
Five collaborations involving autistic scientists and experts are advancing autism research, from lending support for theories of the condition to shoring up trials of new treatments.

Run a Search

ADVERTISEMENT